Skip to main content
Premium Trial:

Request an Annual Quote

EMBL Licenses IMMD s KeyMolnet Bioinformatics Platform

NEW YORK, Dec. 22 (GenomeWeb News) - The European Molecular Biology Laboratory has licensed the KeyMolnet pathway informatics platform from the Institute of Medicinal Molecular Design, the Japan-based institute said today.

 

EMBL will use KeyMolnet at its main laboratory in Heidelberg, Germany, and at its outstations.

 

KeyMolnet is a database of information on the relationships among genes, molecules, diseases, pathways, and drugs that have been manually curated from literature by IMMD biologists.

 

The Genomics and Chemical Biology Core Facilities will provide KeyMolnet access to EMBL's research community and collaborators.

 

Financial details were not disclosed.